Production (Stage)
Tenax Therapeutics, Inc.
TENX
$6.07
$0.020.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 111.45M | 94.85M | 98.31M | 9.38M | 12.55M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 524.00K | 1.77M | 1.44M | 1.18M | 1.84M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 88.00K | 64.00K | 33.90K | 50.30K | 66.60K |
| Total Current Assets | 112.06M | 96.69M | 99.78M | 10.62M | 14.46M |
|
|
|||||
| Total Current Assets | 112.06M | 96.69M | 99.78M | 10.62M | 14.46M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 1.10K | 1.10K | 1.10K |
| Total Assets | 112.06M | 96.69M | 99.78M | 10.62M | 14.46M |
|
|
|||||
| Total Accounts Payable | 1.84M | 3.16M | 1.58M | 869.70K | 1.08M |
| Total Accrued Expenses | 929.00K | 1.54M | 977.50K | 592.40K | 536.40K |
| Short-term Debt | -- | -- | -- | 278.80K | 413.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.77M | 4.69M | 2.56M | 1.74M | 2.03M |
|
|
|||||
| Total Current Liabilities | 2.77M | 4.69M | 2.56M | 1.74M | 2.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 278.80K | 413.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.77M | 4.69M | 2.56M | 1.74M | 2.03M |
|
|
|||||
| Common Stock & APIC | 434.55M | 406.85M | 405.81M | 313.50M | 313.48M |
| Retained Earnings | -325.26M | -314.86M | -308.59M | -304.63M | -301.05M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 109.29M | 91.99M | 97.22M | 8.88M | 12.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 109.29M | 91.99M | 97.22M | 8.88M | 12.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 109.29M | 91.99M | 97.22M | 8.88M | 12.43M |
|
|
|||||